Page 41 - 南京医科大学自然版
P. 41

第45卷第11期 周锋盛,袁        琳,浦浙宁,等. 超声黏弹性成像瘤周参数对BI⁃RADS 4类乳腺结节良恶性的预测价值[J].
                 2025年11月                    南京医科大学学报(自然科学版),2025,45(11):1563-1571                      ·1571 ·


               [22] 黄淑念. 黏弹性及剪切波弹性定量参数联合 BI⁃RADS                       Ultrasound in Medicine,2025,41(2):136-140
                    分类量化评分诊断乳腺结节的价值探讨[D]. 百色:右                   [25]曹钟毓,周       鸿,翟   蓓,等. 剪切波弹性成像联合超微

                    江民族医学院,2024                                        血管成像对BI⁃RADS 4类乳腺结节的诊断价值[J]. 成
                    HUANG S N. The value of viscoelastic and shear⁃wave  都医学院学报,2024,19(6):958-961
                    elastic parameter combined with BI ⁃ RADS quantified  CAO Z Y,ZHOU H,ZHAI B,et al. Value of shear wave
                    score in the diagnosis of breast nodules[D]. Baise:Youji⁃  elastography combined with superb microvascular imaging
                    ang Medical College for Nationalities,2024         in the diagnosis of B⁃RADS4 breast nodule[J]. Journal of
               [23] JIA W R,XIA S J,JIA X H,et al. Ultrasound viscosity  Chengdu Medical College,2024,19(6):958-961
                     imaging in breast lesions:a multicenter prospective  [26]李易凤,陈  武,刘晓芳,等. 剪切波弹性成像在乳腺结
                     study[J]. Acad Radiol,2024,31(9):3499-3510        节 BI⁃RADS 3、4a 类中的应用价值[J]. 中国超声医学
               [24]梁汝娜,张瑾晖,井佳瑜,等. 基于常规超声与超声造影                          杂志,2020,36(7):613-616
                    特征构建列线图对乳腺BI⁃RADS 4类病变风险预测的                        LI Y F,CHEN W,LIU X F,et al. Application value of
                    研究[J]. 中国超声医学杂志,2025,41(2):136-140                 shear⁃wave elastography in category BI⁃RADS 3 and 4a of
                    LI R N,ZHANG J H,JIN J Y,et al. Study on risk predic⁃  breast lesions[J]. Chinese Journal of Ultrasound in Medi⁃
                    tion of BI⁃RADS 4 breast lesions by constructing a nomo⁃  cine,2020,36(7):613-616
                    gram model based on conventional ultrasound and contrast⁃              [收稿日期] 2025-08-06
                    enhanced ultrasound features[J]. Chinese Journal of                         (本文编辑:蒋      莉)



                


               (上接第1545页)                                              itor of cyclin⁃dependent kinases controls DNA replication
                    against triple⁃negative breast cancer[J]. Chem Biol Inter⁃  by interaction with PCNA[J]. Nature,1994,369(6481):
                    act,2023,369:110260                                574-578
               [14]ZHU J R,WANG L,NIE X Y,et al. RBMS3⁃loss impedes  [21]ZHANG C,WANG S F,LU X Q,et al. POP1 Facilitates
                    TRIM21⁃induced ubiquitination of ANGPT2 in an RNA⁃  proliferation in triple⁃negative breast cancer via m6A⁃
                    independent manner and drives sorafenib resistance in  dependent degradation of CDKN1A mRNA[J]. Research
                    hepatocellular carcinoma[J]. Oncogene,2025,44(21):  (Wash D C),2024,7:0472
                    1620-1633                                    [22]奚佩雯,胡        玥,张    旭,等. RBM7 在乳腺癌细胞
               [15]ZHANG Q S,HAN S Q,ZHANG X Y,et al. Metformin en⁃    BT474 中的表达及其与 P21 的关系[J]. 南京医科大学
                    hances PD⁃L1 inhibitor efficacy in ovarian cancer by modu⁃  学报(自然科学版),2020,40(2):160-165
                    lating the immune microenvironment and RBMS3 expres⁃  XI P W,HU Y,ZHANG X,et al. Expression of RBM7 in
                    sion[J]. FASEB J,2025,39(11):e70705                breast cancer cell line BT474 and its relationship with
               [16]RUAN X L,LIU Y H,WANG P,et al. RBMS3⁃induced        P21[J]. Journal of Nanjing Medical University(Natural
                    circHECTD1 encoded a novel protein to suppress the  Sciences),2020,40(2):160-165
                    vasculogenic mimicry formation in glioblastoma multi⁃  [23]XI P W,ZHANG X,ZHU L,et al. Oncogenic action of the
                    forme[J]. Cell Death Dis,2023,14(11):745           exosome cofactor RBM7 by stabilization of CDK1 mRNA
               [17]ENGELAND K. Cell cycle regulation :p53 ⁃ p21 ⁃ RB   in breast cancer[J]. NPJ Breast Cancer,2020,6:58
                    signaling[J]. Cell Death Differ,2022,29(5):946-960  [24]XU F,XIA T,XU Q T,et al. RBMS2 chemosensitizes
               [18]TICLI G,CAZZALINI O,STIVALA L A,et al. Revisiting   breast cancer cells to doxorubicin by regulating BMF ex⁃
                                  CDKN1A
                    the function of p21  in DNA repair:the influence of  pression[J]. Int J Biol Sci,2022,18(4):1724-1736
                    protein interactions and stability[J]. Int J Mol Sci,2022,  [25]XIA T,DAI X Y,SANG M Y,et al. IGF2BP2 drives cell
                    23(13):7058                                        cycle progression in triple ⁃ negative breast cancer by
               [19]THANGAVELU L,ALTAMIMI A S A,GHABOURA N,             recruiting EIF4A1 to promote the m6A ⁃ modified CDK6

                    et al. Targeting the p53⁃p21 axis in liver cancer:linking  translation initiation process[J]. Adv Sci(Weinh),2024,
                    cellular senescence to tumor suppression and progres⁃  11(1):e2305142
                    sion[J]. Pathol Res Pract,2024,263:155652                              [收稿日期] 2025-07-27
               [20]WAGA S,HANNON G J,BEACH D,et al. The p21 inhib⁃                              (本文编辑:陈汐敏)
   36   37   38   39   40   41   42   43   44   45   46